| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1055-9965.EPI-05-0991 |
| P698 | PubMed publication ID | 16775171 |
| P50 | author | Anneleen Kuijsten | Q59676970 |
| Ilja C. W. Arts | Q42845827 | ||
| P2093 | author name string | Pieter van't Veer | |
| Ellen Kampman | |||
| Peter C H Hollman | |||
| P2860 | cites work | Risk of Colorectal Adenomas in Relation to Meat Consumption, Meat Preparation, and Genetic Susceptibility in a Dutch Population | Q57552189 |
| A short questionnaire for the measurement of habitual physical activity in epidemiological studies | Q70501617 | ||
| Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens | Q72951655 | ||
| Antioxidant Activity of Secoisolariciresinol Diglucoside-derived Metabolites, Secoisolariciresinol, Enterodiol, and Enterolactone | Q73150008 | ||
| Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone | Q73518807 | ||
| Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside | Q81584909 | ||
| Colorectal cancer | Q93917269 | ||
| Case-control study of phyto-oestrogens and breast cancer | Q34065312 | ||
| In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol | Q34083943 | ||
| Use of oral antimicrobials decreases serum enterolactone concentration | Q34116099 | ||
| Lignan formation in man--microbial involvement and possible roles in relation to cancer | Q34246281 | ||
| Origin of lignans in mammals and identification of a precursor from plants | Q34253498 | ||
| Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol | Q34416493 | ||
| Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study | Q34558340 | ||
| Production and metabolism of lignans by the human faecal flora | Q34564101 | ||
| Dietary lignans: potential role in cancer prevention | Q36110267 | ||
| Foodstuffs and colorectal cancer risk: a review | Q36313850 | ||
| Circulating enterolactone and risk of breast cancer: a prospective study in New York | Q36625914 | ||
| Dietary phytoestrogens and cancer: in vitro and in vivo studies | Q41638504 | ||
| The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients | Q42437568 | ||
| The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity | Q42519355 | ||
| Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study | Q43469566 | ||
| Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study | Q43956075 | ||
| An incident case-referent study on plasma enterolactone and breast cancer risk | Q44145829 | ||
| Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice | Q44525714 | ||
| Serum enterolactone levels and the risk of breast cancer in women with palpable cysts | Q44700963 | ||
| No effect on adenoma formation in Min mice after moderate amount of flaxseed. | Q44996442 | ||
| Reports: plasma and dietary phytoestrogens and risk of premalignant lesions of the cervix | Q45110703 | ||
| Prospective study of plasma enterolactone and prostate cancer risk (Sweden). | Q46413658 | ||
| A validated method for the quantification of enterodiol and enterolactone in plasma using isotope dilution liquid chromatography with tandem mass spectrometry | Q46582287 | ||
| The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation. | Q46586344 | ||
| The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. | Q52005065 | ||
| Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. | Q53423051 | ||
| P433 | issue | 6 | |
| P921 | main subject | colorectal adenoma | Q2825480 |
| P304 | page(s) | 1132-1136 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Plasma enterolignans are associated with lower colorectal adenoma risk | |
| P478 | volume | 15 |
| Q61455369 | A Review of Lignan Metabolism, Milk Enterolactone Concentration, and Antioxidant Status of Dairy Cows Fed Flaxseed |
| Q39899989 | Absorption of plant lignans from cereals in an experimental pig model |
| Q91641147 | Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives |
| Q92508909 | Bacterial metabolism as responsible of beneficial effects of phytoestrogens on human health |
| Q38033464 | Dietary lifestyle and colorectal cancer onset, recurrence, and survival: myth or reality? |
| Q35605926 | Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial |
| Q34994426 | Dietary phenolics: chemistry, bioavailability and effects on health |
| Q37951807 | Dietary, endocrine, and metabolic factors in the development of colorectal cancer. |
| Q54394527 | Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. |
| Q36267739 | Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors |
| Q88574434 | Enterodiol is Actively Transported by Rat Liver Cell Membranes |
| Q35353462 | Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United States |
| Q36558602 | Estrogens, phytoestrogens and colorectal neoproliferative lesions. |
| Q92007842 | Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans |
| Q88991278 | Flaxseed Bioactive Compounds and Colorectal Cancer Prevention |
| Q91796711 | Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets |
| Q24654943 | Gastrointestinal microflora, food components and colon cancer prevention |
| Q43202598 | Grain foods and health: a primer for clinicians |
| Q37793208 | Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer |
| Q42574371 | Human microbiome and cancer: an insight |
| Q59280883 | In VitroModels for Studying Secondary Plant Metabolite Digestion and Bioaccessibility |
| Q41736897 | Interactions of corn meal or molasses with a soybean-sunflower meal mix or flaxseed meal on production, milk fatty acid composition, and nutrient utilization in dairy cows fed grass hay-based diets. |
| Q46325235 | Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study |
| Q60491234 | Lignans (Neolignans) and Allyl/Propenyl Phenols: Biogenesis, Structural Biology, and Biological/Human Health Considerations |
| Q34702636 | Lignans and human health |
| Q39170434 | Lignans extracted from Vitex negundo possess cytotoxic activity by G2/M phase cell cycle arrest and apoptosis induction |
| Q39698992 | Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling. |
| Q35822509 | Microbiome impact on metabolism and function of sex, thyroid, growth and parathyroid hormones |
| Q95318912 | Microbiota and cancer: host cellular mechanisms activated by gut microbial metabolites |
| Q38114380 | Oestrogenicity of prenylflavonoids from hops: activation of pro-oestrogens by intestinal bacteria |
| Q30238995 | Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies |
| Q62819473 | Phytoestrogens |
| Q43257856 | Plasma enterolactone and risk of colon and rectal cancer in a case-cohort study of Danish men and women |
| Q46810006 | Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q38890674 | Prospective Study of Dietary Phytoestrogen Intake and the Risk of Colorectal Cancer |
| Q39043398 | Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma |
| Q38462821 | Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population |
| Q51158260 | Role of ABCG2 in transport of the mammalian lignan enterolactone and its secretion into milk in Abcg2 knockout mice. |
| Q62846540 | Rye Consumption and the Risk of Colorectal Cancer |
| Q92353195 | Serum enterolactone concentrations are low in colon but not in rectal cancer patients |
| Q102060229 | Technical note: Quantification of lignans in the urine, milk, and plasma of flaxseed cake-fed dairy sheep |
| Q61736860 | The Breast Cancer Resistance Protein (BCRP/ABCG2) influences the levels of enterolignans and their metabolites in plasma, milk and mammary gland |
| Q37775286 | The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals |
| Q33358382 | Unravelling of the health effects of polyphenols is a complex puzzle complicated by metabolism |
| Q102979205 | Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA |
| Q37362982 | Vitexins, nature-derived lignan compounds, induce apoptosis and suppress tumor growth. |
| Q37963027 | Whole grains: benefits and challenges |
Search more.